Founder of BioNTech SE, Ganymed Pharmaceuticals AG, TRON - Translationale Onkologie an der Universitätsmedizin der and Ci3 Management UG, Ugur Sahin holds the position of Chief Executive Officer of BioNTech SE and Managing Director at reBOOST Management GmbH (a subsidiary of BioNTech SE) and Managing Director at Medine GmbH.

He is also Professor at Universitätsmedizin der Johannes Gutenberg-Universität Mainz.

In his past career Ugur Sahin held the position of Chief Medical Officer at Ganymed Pharmaceuticals AG and Co-Managing Director at TRON - Translationale Onkologie an der Universitätsmedizin der.

He received a doctorate from Universität zu Köln.